125 related articles for article (PubMed ID: 38606543)
1. Transition from asymptomatic to symptomatic systolic chronic heart failure: rationale and design of TransitionCHF.
Sandek A; Edelmann F; Gertler C; Friede T; Wachter R; Hasenfuß G;
ESC Heart Fail; 2024 Apr; ():. PubMed ID: 38606543
[TBL] [Abstract][Full Text] [Related]
2. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
[TBL] [Abstract][Full Text] [Related]
3. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K;
Circulation; 2004 Oct; 110(17):2618-26. PubMed ID: 15492298
[TBL] [Abstract][Full Text] [Related]
4. Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design.
Koehler F; Winkler S; Schieber M; Sechtem U; Stangl K; Böhm M; Boll H; Kim SS; Koehler K; Lücke S; Honold M; Heinze P; Schweizer T; Braecklein M; Kirwan BA; Gelbrich G; Anker SD;
Eur J Heart Fail; 2010 Dec; 12(12):1354-62. PubMed ID: 21098580
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of individuals with asymptomatic left ventricular systolic dysfunction in the multi-ethnic study of atherosclerosis (MESA).
Yeboah J; Rodriguez CJ; Stacey B; Lima JA; Liu S; Carr JJ; Hundley WG; Herrington DM
Circulation; 2012 Dec; 126(23):2713-9. PubMed ID: 23124035
[TBL] [Abstract][Full Text] [Related]
6. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.
Linde C; Abraham WT; Gold MR; St John Sutton M; Ghio S; Daubert C;
J Am Coll Cardiol; 2008 Dec; 52(23):1834-1843. PubMed ID: 19038680
[TBL] [Abstract][Full Text] [Related]
8. Clinical Implications of Functional Mitral Regurgitation Severity in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF).
Naser N
Med Arch; 2022 Feb; 76(1):17-22. PubMed ID: 35422569
[TBL] [Abstract][Full Text] [Related]
9. The Effectiveness of Eplerenone vs Spironolactone on Left Ventricular Systolic Function, Hospitalization and Cardiovascular Death in Patients With Chronic Heart Failure-HFrEF.
Naser N; Durak-Nalbantic A; Sabanovic-Bajramovic N; Karic A
Med Arch; 2023 Apr; 77(2):105-111. PubMed ID: 37260796
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. The preserved autonomic functions may provide the asymptomatic clinical status in heart failure despite advanced left ventricular systolic dysfunction.
Kocaman SA; Taçoy G; Ozdemir M; Açıkgöz SK; Cengel A
Anadolu Kardiyol Derg; 2010 Dec; 10(6):519-25. PubMed ID: 20952357
[TBL] [Abstract][Full Text] [Related]
12. Asymptomatic Left Ventricle Systolic Dysfunction.
Sara JD; Toya T; Taher R; Lerman A; Gersh B; Anavekar NS
Eur Cardiol; 2020 Feb; 15():e13. PubMed ID: 32373186
[TBL] [Abstract][Full Text] [Related]
13. Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure: A Systematic Overview and Meta-Analysis.
Echouffo-Tcheugui JB; Erqou S; Butler J; Yancy CW; Fonarow GC
JACC Heart Fail; 2016 Apr; 4(4):237-48. PubMed ID: 26682794
[TBL] [Abstract][Full Text] [Related]
14. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction.
Dries DL; Exner DV; Gersh BJ; Domanski MJ; Waclawiw MA; Stevenson LW
J Am Coll Cardiol; 1998 Sep; 32(3):695-703. PubMed ID: 9741514
[TBL] [Abstract][Full Text] [Related]
15. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction.
Houard L; Amzulescu MS; Colin G; Langet H; Militaru S; Rousseau MF; Ahn SA; Vanoverschelde JJ; Pouleur AC; Gerber BL
Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011680. PubMed ID: 33438438
[TBL] [Abstract][Full Text] [Related]
17. Asymptomatic left ventricular systolic dysfunction in essential hypertension: prevalence, determinants, and prognostic value.
Verdecchia P; Angeli F; Gattobigio R; Sardone M; Porcellati C
Hypertension; 2005 Mar; 45(3):412-8. PubMed ID: 15655115
[TBL] [Abstract][Full Text] [Related]
18. Systematic review: cardiac resynchronization in patients with symptomatic heart failure.
McAlister FA; Ezekowitz JA; Wiebe N; Rowe B; Spooner C; Crumley E; Hartling L; Klassen T; Abraham W
Ann Intern Med; 2004 Sep; 141(5):381-90. PubMed ID: 15353430
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone receptor antagonists decrease mortality and cardiovascular hospitalizations in chronic heart failure with reduced left ventricular ejection fraction, but not in chronic heart failure with preserved left ventricular ejection fraction: a meta-analysis of randomized controlled trials.
DE Vecchis R; Ariano C
Minerva Cardioangiol; 2017 Aug; 65(4):427-442. PubMed ID: 27958695
[TBL] [Abstract][Full Text] [Related]
20. Comparison of characteristics and outcomes of asymptomatic versus symptomatic left ventricular dysfunction in subjects 65 years old or older (from the Cardiovascular Health Study).
Pandhi J; Gottdiener JS; Bartz TM; Kop WJ; Mehra MR
Am J Cardiol; 2011 Jun; 107(11):1667-74. PubMed ID: 21575752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
